Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Breast Cancer Female × durvalumab × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Papillomavirus Infections 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Hydronephrosis 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Breast Cancer Female 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

durvalumab 1 abemaciclib 1 Vitamin D 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04088032 2020-07-16

Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Stony Brook University

Phase EARLY_PHASE1 Withdrawn

BreastOther neoplasm

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡